| ・ | Asakawa M, Takano H, Nagai T, Uozumi H, Hasegawa H, Kubota N, Saito T, Masuda Y, Kadowaki T, Komuro I. Peroxisome proliferator-activated receptor g plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo. Circulation 105: 1240-1246, 2002. |
| ・ | Aikawa R, Nagai T, Kudoh S, Zou Y, Tanaka M, Tamura M, Akazawa H, Takano H, Nagai R, Komuro I. Integrins play a critical role in mechanical stress-induced p38 MAPK activation. Hypertension 39: 233-238, 2002. |
| ・ | Takimoto E, Yao A, Toko H, Takano H, Shimoyama M, Sonoda M, Wakimoto K, Takahashi T, Akazawa H, Mizukami M, Nagai T, Nagai R, Komuro I. Sodium calcium exchanger plays a key role in alteration of cardiac function in response to pressure overload. FASEB Journal 16: 373-378, 2002. |
| ・ | Toko H, Zhu W, Takimoto E, Shiojima I, Hiroi Y, Zou Y, Oka T, Akazawa H, Mizukami M, Sakamoto M, Terasaki F, Kitaura Y, Takano H, Nagai T, Nagai R, Komuro I. Csx/Nkx2-5 is required for homeostasis and survival of cardiac myocytes in the adult heart. Journal of Biological Chemistry 277: 24735-24743, 2002. |
| ・ | Yamazaki M, Takano H, Miyauchi H, Daimon M, Funabashi N, Nagai T, Komiyama N, Yoshida K, Komuro I. Detection of Takayasu arteritis in early stage by computed tomography. International Journal of Cardiology 85: 305-307, 2002. |
| ・ | Aikawa R, Nitta-Komatsubara Y, Kudoh S, Takano H, Nagai T, Yazaki Y, Nagai R, Komuro I. Reactive oxygen species induce cardiomyocyte apoptosis partly through TNF-a. Cytokine 18: 179-183, 2002. |
| ・ | Ikeda Y, Hiroi Y, Hosoda T, Utsunomiya T, Matsuo S, Ito T, Inoue J, Sumiyoshi T, Takano H, Nagai R, Komuro I. Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease. Circulation Journal 66: 561-563, 2002. |
| ・ | Zou Y, Yamazaki T, Nakagawa K, Yamada H, Iriguchi N, Toko H, Takano H, Akazawa H, Nagai R, Komuro I. Continuous blockade of L-type Ca2+ channels suppresses activation of calcineurin and development of cardiac hypertrophy in spontaneously hypertensive rats. Hypertension Research 25: 117-124, 2002. |
| ・ | Takano H, Zou Y, Akazawa H, Toko H, Mizukami M, Hasegawa H, Asakawa M, Nagai T, Komuro I. Inhibitory molecules in signal transduction pathways of cardiac hypertrophy. Hypertension Research 25: 491-498, 2002. |
| ・ | Takano H, Komuro I. Roles of peroxisome proliferator-activated receptor g in cardiovascular disease. Journal of Diabetes and its Complications 16: 108-114, 2002. |
| ・ | Takano H, Komuro I. Beta-blockers have beneficial effects even on unclassified cardiomyopathy such as isolated ventricular noncompaction. Internal Medicine 41: 601-602, 2002. |
| ・ | Zou Y, Takano H, Akazawa H, Nagai T, Mizukami M, Komuro I. Molecularand cellular mechanisms of mechanical stress-induced cardiac hypertrophy. Endocrine Journal 49: 1-13, 2002. |
| ・ |
高野博之、小室一成 心血管系疾患におけるPPARgの役割 実験治療 665: 56-60, 2002. |
| ・ |
高野博之、小室一成 心肥大シグナル伝達経路を抑制する分子. 実験治療 667: 60-63, 2002. |
| ・ |
高野博之、小室一成 PPARgと心肥大. 医学のあゆみ 201: 492-494, 2002. |
| ・ |
進藤哲、高野博之、小室一成 アンジオテンシンII受容体拮抗薬の心筋保護作用.アンジオテンシンII受容体拮抗薬 152-164, 2002. |